ACIMTAMIG
UNII ND470TT8Y3

Substance Identification & Data

This profile provides standardized clinical and technical data for Acimtamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ND470TT8Y3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2738880-26-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ND470TT8Y3
CAS Registry Number
2738880-26-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ACIMTAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12484
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Acimtamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ACIMTAMIG

Common Names & Synonyms

ACIMTAMIG [INN]
AFM 13 [WHO-DD]
AFM13 (ANTI CD30 X ANTI CD16)
ANTI-CD30/CD16A MONOCLONAL ANTIBODY AFM13
IMMUNOGLOBULIN, ANTI-(HUMAN FC.GAMMA.RIIIA RECEPTOR) (HUMAN HEAVY CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GGS)3 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD30 ANTIGEN) (HUMAN-MUS MUSCULUS SINGLE-CHAIN FV FRAGMENT VL-(GGS)3-VH) FUSION PROTEIN WITH PEPTIDE LINKER (GGS)3 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN FC.GAMMA.RIIIA RECEPTOR) (HUMAN .LAMBDA.-CHAIN V-J REGION), DIMER

Technical Codes

AFM13
AFM-13